Cadenza Bio Alternatives & Competitors
12 companies similar to Cadenza Bio — Preclinical biotech company developing a series of novel drugs for treatment of...
Companies similar to Cadenza Bio
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
Proclara Biosciences
Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggre...
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Rival Readout
Competing with Cadenza Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
CaSRevolution
A new hope for patients affected by Alzheimer’s disease
Milan, Italy
GeNeuro SA
We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS...
Mediar Therapeutics
Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt...
Boston, United States
Evommune
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
Palo Alto, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
aTyr Pharma
aTyr is a biotherapeutics company engaged in the development of innovative medicines based...
San Diego, United States
NeuroScientific Biopharmaceuticals Ltd
Novel drug therapies for neurodegenerative conditions
Australia
About Cadenza Bio
Cadenza Bio is a preclinical biotech company focused on developing a series of novel drugs for the treatment of demyelinating and inflammatory diseases. Founded in 2022, the company's goal is to accelerate and support the development of non-steroidal, highly selective compounds that target Estrogen Receptor β (ERβ). Th...
Preclinical Biotech, Novel Drug Development, Demyelinating Diseases, Inflammatory Diseases, Estrogen Receptor β (ERβ), Therapeutic Efficacy, Multiple Sclerosis, Endometriosis, Disease Progression, Patient Empowerment, Quality Of Life, Healthcare Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cadenza Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cadenza Bio on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
